Ost-müük Vericel Corp Ord - VCEL CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | 0.11 | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.030779% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | -0.013666% | ||||||||
Ööpäeva tasu aeg | 22:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | 28.34 |
Avatud* | 28.82 |
Aastane muutus* | -18.75% |
Päeva ulatus* | 28.82 - 30.7 |
52 nädala ulatus | 17.30-43.97 |
Keskmine maht (10 päeva) | 301.32K |
Keskmine maht (3 kuud) | 9.82M |
Turukapitalisatsioon | 1.30B |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 47.22M |
Tulu | 159.26M |
EPS | -0.38 |
Dividendid (% kasumist) | N/A |
Beeta | 1.74 |
Järgmine tuluaruande kuupäev | Feb 22, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|---|---|---|---|---|---|
Feb 1, 2023 | 28.34 | 0.94 | 3.43% | 27.40 | 28.65 | 27.14 |
Jan 31, 2023 | 27.41 | 0.44 | 1.63% | 26.97 | 27.48 | 26.89 |
Jan 30, 2023 | 26.98 | -0.90 | -3.23% | 27.88 | 28.23 | 26.84 |
Jan 27, 2023 | 28.50 | 1.03 | 3.75% | 27.47 | 28.83 | 27.47 |
Jan 26, 2023 | 27.80 | 0.32 | 1.16% | 27.48 | 28.27 | 27.44 |
Jan 25, 2023 | 27.88 | 0.41 | 1.49% | 27.47 | 28.40 | 27.20 |
Jan 24, 2023 | 28.60 | 0.02 | 0.07% | 28.58 | 29.37 | 28.41 |
Jan 23, 2023 | 28.95 | 0.16 | 0.56% | 28.79 | 29.39 | 28.19 |
Jan 20, 2023 | 28.93 | 0.96 | 3.43% | 27.97 | 29.24 | 27.97 |
Jan 19, 2023 | 28.36 | -0.11 | -0.39% | 28.47 | 28.73 | 27.92 |
Jan 18, 2023 | 28.95 | 0.19 | 0.66% | 28.76 | 29.93 | 28.64 |
Jan 17, 2023 | 29.24 | 1.77 | 6.44% | 27.47 | 29.33 | 27.47 |
Jan 13, 2023 | 28.15 | -0.80 | -2.76% | 28.95 | 30.01 | 27.99 |
Jan 12, 2023 | 29.45 | 2.47 | 9.15% | 26.98 | 29.74 | 26.98 |
Jan 11, 2023 | 27.56 | -0.01 | -0.04% | 27.57 | 27.98 | 26.79 |
Jan 10, 2023 | 27.67 | 4.15 | 17.64% | 23.52 | 27.79 | 23.52 |
Jan 9, 2023 | 23.80 | -0.17 | -0.71% | 23.97 | 24.65 | 23.45 |
Jan 6, 2023 | 23.84 | -0.70 | -2.85% | 24.54 | 25.40 | 23.34 |
Jan 5, 2023 | 24.43 | -0.23 | -0.93% | 24.66 | 25.19 | 24.27 |
Jan 4, 2023 | 25.46 | 0.32 | 1.27% | 25.14 | 25.92 | 24.69 |
Vericel Corp Ord Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Kogutulu | 54.383 | 63.924 | 90.857 | 117.85 | 124.179 | 156.184 |
Tulu | 54.383 | 63.924 | 90.857 | 117.85 | 124.179 | 156.184 |
Kulud, Kokku | 28.307 | 30.354 | 32.16 | 37.571 | 39.951 | 50.159 |
Brutokasum | 26.076 | 33.57 | 58.697 | 80.279 | 84.228 | 106.025 |
Kogu tegevuskulu | 73.628 | 79.768 | 95.604 | 129.101 | 121.807 | 164.038 |
Müük/Üldine/admin kulud, kokku | 27.388 | 35.61 | 49.007 | 61.139 | 68.836 | 97.592 |
Uuringud ja arendus | 15.295 | 12.944 | 13.599 | 30.391 | 13.02 | 16.287 |
Ootamatud kulutused (tulu) | 2.638 | 0.86 | 0.838 | 0 | 0 | |
Tulud majandustegevusest | -19.245 | -15.844 | -4.747 | -11.251 | 2.372 | -7.854 |
Intressitulud (kulu), muud tulud, neto | -0.311 | -1.35 | -3.359 | 1.606 | 0.685 | 0.22 |
Muud, neto | -0.01 | -0.092 | -0.031 | -0.02 | -0.013 | 0.052 |
Netotulu enne makse | -19.566 | -17.286 | -8.137 | -9.665 | 3.044 | -7.582 |
Netotulu pärast makse | -19.566 | -17.286 | -8.137 | -9.665 | 2.864 | -7.471 |
Netotulu enne erikulusid | -19.566 | -17.286 | -8.137 | -9.665 | 2.864 | -7.471 |
Netotulu | -19.566 | -17.286 | -8.137 | -9.665 | 2.864 | -7.471 |
Total Adjustments to Net Income | -7.579 | 0 | 0 | |||
Arvestatav tulu, v a erikulud | -27.145 | -17.286 | -8.137 | -9.665 | 2.864 | -7.471 |
Arvestatav tulu, koos erikuludega | -27.145 | -17.286 | -8.137 | -9.665 | 2.864 | -7.471 |
Jaotamisele kuuluv netotulu | -27.145 | -17.286 | -8.137 | -9.665 | 2.864 | -7.471 |
Keskmine jaotamisele kuuluv aktsia kohta | 23.093 | 33.355 | 40.242 | 44.18 | 47.282 | 46.472 |
Jaotatav EPS, v a erakorralised kulud | -1.17546 | -0.51824 | -0.2022 | -0.21876 | 0.06057 | -0.16076 |
Jaotamisele kuuluv normaal-EPS | -1.06123 | -0.49246 | -0.18138 | -0.21876 | 0.06057 | -0.16076 |
Erakorralised kulud kokku | 0 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Kogutulu | 34.568 | 39.519 | 34.506 | 47.591 | 36.074 |
Tulu | 34.568 | 39.519 | 34.506 | 47.591 | 36.074 |
Kulud, Kokku | 11.583 | 12.609 | 12.408 | 13.559 | 12.622 |
Brutokasum | 22.985 | 26.91 | 22.098 | 34.032 | 23.452 |
Kogu tegevuskulu | 37.873 | 43.248 | 39.467 | 43.45 | 43.347 |
Müük/Üldine/admin kulud, kokku | 22.66 | 26.19 | 22.775 | 25.967 | 25.865 |
Uuringud ja arendus | 3.63 | 4.449 | 4.284 | 3.924 | 4.86 |
Tulud majandustegevusest | -3.305 | -3.729 | -4.961 | 4.141 | -7.273 |
Intressitulud (kulu), muud tulud, neto | 0.075 | 0.042 | 0.043 | 0.06 | 0.07 |
Muud, neto | 0.084 | -0.027 | -0.013 | 0.007 | 0.112 |
Netotulu enne makse | -3.146 | -3.714 | -4.931 | 4.208 | -7.091 |
Netotulu pärast makse | -3.289 | -3.786 | -4.931 | 4.534 | -7.091 |
Netotulu enne erikulusid | -3.289 | -3.786 | -4.931 | 4.534 | -7.091 |
Netotulu | -3.289 | -3.786 | -4.931 | 4.534 | -7.091 |
Arvestatav tulu, v a erikulud | -3.289 | -3.786 | -4.931 | 4.535 | -7.091 |
Arvestatav tulu, koos erikuludega | -3.289 | -3.786 | -4.931 | 4.535 | -7.091 |
Jaotamisele kuuluv netotulu | -3.289 | -3.786 | -4.931 | 4.535 | -7.091 |
Keskmine jaotamisele kuuluv aktsia kohta | 45.984 | 46.403 | 46.669 | 46.823 | 46.985 |
Jaotatav EPS, v a erakorralised kulud | -0.07152 | -0.08159 | -0.10566 | 0.09685 | -0.15092 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Jaotamisele kuuluv normaal-EPS | -0.07152 | -0.08159 | -0.10566 | 0.09685 | -0.15092 |
Total Adjustments to Net Income | 0.001 |
- Aastas
- Kvartalis
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Käibevarad kokku | 44.723 | 50.506 | 112.783 | 111.655 | 123.56 | 158.462 |
Raha ja lühiajalised investeeringud | 22.978 | 26.862 | 82.924 | 69.718 | 75.807 | 103.398 |
Raha ja ekvivalendid | 22.978 | 26.862 | 18.286 | 26.889 | 33.62 | 68.33 |
Laekumata arved, neto | 17.093 | 18.27 | 23.454 | 32.168 | 34.504 | 37.437 |
Accounts Receivable - Trade, Net | 17.093 | 18.27 | 23.454 | 32.168 | 34.504 | 37.437 |
Total Inventory | 3.488 | 3.793 | 3.558 | 6.816 | 9.356 | 13.381 |
Other Current Assets, Total | 1.164 | 1.581 | 2.847 | 2.953 | 3.893 | 4.246 |
Total Assets | 48.598 | 54.577 | 118.689 | 153.238 | 205.608 | 243.705 |
Property/Plant/Equipment, Total - Net | 3.875 | 4.071 | 5.906 | 32.247 | 57.738 | 59.028 |
Property/Plant/Equipment, Total - Gross | 10.968 | 10.692 | 13.411 | 41.467 | 69.124 | 73.35 |
Accumulated Depreciation, Total | -7.093 | -6.621 | -7.505 | -9.22 | -11.386 | -14.322 |
Intangibles, Net | 0 | |||||
Total Current Liabilities | 12.853 | 13.09 | 14.792 | 19.795 | 22.483 | 26.052 |
Accounts Payable | 6.535 | 5.552 | 7.108 | 6.345 | 6.755 | 9.016 |
Accrued Expenses | 4.523 | 5.573 | 6.93 | 13.409 | 15.687 | 16.995 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.779 | 0.35 | 0 | 0.041 | 0.041 | 0.041 |
Other Current Liabilities, Total | 1.016 | 1.615 | 0.754 | |||
Total Liabilities | 23.89 | 32.037 | 16.458 | 42.147 | 71.348 | 73.243 |
Total Long Term Debt | 9.35 | 16.888 | 0 | 0.11 | 0.076 | 0.044 |
Long Term Debt | 9.35 | 16.888 | 0 | |||
Other Liabilities, Total | 1.687 | 2.059 | 1.666 | 22.242 | 48.789 | 47.147 |
Total Equity | 24.708 | 22.54 | 102.231 | 111.091 | 134.26 | 170.462 |
Preferred Stock - Non Redeemable, Net | 38.389 | 0 | ||||
Common Stock | 329.72 | 383.02 | 471.18 | 489.749 | 510.061 | 553.902 |
Retained Earnings (Accumulated Deficit) | -343.401 | -360.48 | -368.91 | -378.679 | -375.815 | -383.286 |
Treasury Stock - Common | 0 | |||||
Total Liabilities & Shareholders’ Equity | 48.598 | 54.577 | 118.689 | 153.238 | 205.608 | 243.705 |
Total Common Shares Outstanding | 31.595 | 35.861 | 43.578 | 44.864 | 45.804 | 46.88 |
Total Preferred Shares Outstanding | 0.012 | 0 | ||||
Lühiajalised investeeringud | 64.638 | 42.829 | 42.187 | 35.068 | ||
Other Equity, Total | -0.039 | 0.021 | 0.014 | -0.154 | ||
Long Term Investments | 9.247 | 24.099 | 25.687 | |||
Other Long Term Assets, Total | 0.089 | 0.211 | 0.528 | |||
Capital Lease Obligations | 0.11 | 0.076 | 0.044 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Käibevarad kokku | 127.213 | 138.52 | 144.946 | 158.462 | 151.88 |
Raha ja lühiajalised investeeringud | 83.556 | 90.975 | 98.291 | 103.398 | 100.547 |
Raha ja ekvivalendid | 58.154 | 51.761 | 54.553 | 68.33 | 55.659 |
Lühiajalised investeeringud | 25.402 | 39.214 | 43.738 | 35.068 | 44.888 |
Laekumata arved, neto | 29.122 | 31.732 | 28.91 | 37.437 | 31.855 |
Accounts Receivable - Trade, Net | 29.122 | 31.732 | 28.91 | 37.437 | 31.855 |
Total Inventory | 10.322 | 12.959 | 13.059 | 13.381 | 14.385 |
Other Current Assets, Total | 4.213 | 2.854 | 4.686 | 4.246 | 5.093 |
Total Assets | 211.464 | 221.945 | 224.143 | 243.705 | 240.288 |
Property/Plant/Equipment, Total - Net | 58.019 | 58.388 | 58.532 | 59.028 | 59.104 |
Property/Plant/Equipment, Total - Gross | 70.188 | 71.251 | 72.074 | 73.35 | 74.299 |
Accumulated Depreciation, Total | -12.169 | -12.863 | -13.542 | -14.322 | -15.195 |
Long Term Investments | 26.021 | 24.826 | 20.235 | 25.687 | 22.803 |
Other Long Term Assets, Total | 0.211 | 0.211 | 0.43 | 0.528 | 6.501 |
Total Current Liabilities | 23.23 | 23.863 | 18.828 | 26.052 | 21.731 |
Accounts Payable | 8.826 | 8.134 | 5.575 | 9.016 | 7.75 |
Accrued Expenses | 14.363 | 15.688 | 13.212 | 16.995 | 13.94 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0.041 | 0.041 | 0.041 | 0.041 | |
Total Liabilities | 71.255 | 70.853 | 67.363 | 73.243 | 67.803 |
Total Long Term Debt | 0.057 | 0.062 | 0.042 | 0.044 | 0.019 |
Capital Lease Obligations | 0.057 | 0.062 | 0.042 | 0.044 | 0.019 |
Other Liabilities, Total | 47.968 | 46.928 | 48.493 | 47.147 | 46.053 |
Total Equity | 140.209 | 151.092 | 156.78 | 170.462 | 172.485 |
Common Stock | 519.36 | 534.005 | 544.624 | 553.902 | 563.475 |
Retained Earnings (Accumulated Deficit) | -379.104 | -382.89 | -387.821 | -383.286 | -390.377 |
Other Equity, Total | -0.047 | -0.023 | -0.023 | -0.154 | -0.613 |
Total Liabilities & Shareholders’ Equity | 211.464 | 221.945 | 224.143 | 243.705 | 240.288 |
Total Common Shares Outstanding | 46.225 | 46.579 | 46.767 | 46.88 | 47.081 |
Other Current Liabilities, Total | 0.041 |
- Aastas
- Kvartalis
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Netotulu/algväärtus | -19.566 | -17.286 | -8.137 | -9.665 | 2.864 | -7.471 |
Raha majandustegevusest | -19.892 | -13.183 | -0.412 | -7.183 | 17.572 | 29.04 |
Raha majandustegevusest | 1.886 | 1.612 | 1.426 | 1.744 | 2.383 | 2.965 |
Mittelikviidsed varad | 6.847 | 4.856 | 10.084 | 15.398 | 18.699 | 39.7 |
Makstud intressid | 0.226 | 0.931 | 2.23 | 0 | 0.006 | 0.004 |
Muutused tööjõus | -9.059 | -2.365 | -3.785 | -14.66 | -6.374 | -6.154 |
Tulu investeeringutelt | -1.415 | -1.51 | -67.027 | 10.615 | -17.16 | -3.501 |
Kapitalikulutused | -1.415 | -1.51 | -2.678 | -2.616 | -2.626 | -7.915 |
Muud rahavood investeeringutelt, kokku | 0 | 0 | -64.349 | 13.231 | -14.534 | 4.414 |
Rahavood investeeringutelt | 29.704 | 18.577 | 58.863 | 5.26 | 6.441 | 9.171 |
Rahavoogudesse investeerimine | -0.213 | -0.613 | -0.71 | -0.026 | -0.191 | -2.013 |
Aktsiate emiteerimine (tagasiost), neto | 19.455 | 12.437 | 77.105 | 5.286 | 6.632 | 11.184 |
Laenu väljastamine (kustutamine), neto | 10.462 | 6.753 | -17.532 | 0 | 0 | |
Muutused valuutakursside kõikumisest | 0 | |||||
Rahaline kogumuutus | 8.397 | 3.884 | -8.576 | 8.692 | 6.853 | 34.71 |
Cash Taxes Paid | 0.1 | 0 | 0 | 0.379 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -3.289 | -7.075 | -12.006 | -7.471 | -7.091 |
Cash From Operating Activities | 10.086 | 14.855 | 18.489 | 29.04 | 3.468 |
Cash From Operating Activities | 0.811 | 1.506 | 2.185 | 2.965 | 0.873 |
Non-Cash Items | 8.443 | 20.72 | 30.655 | 39.7 | 10.805 |
Cash Interest Paid | 0.001 | 0.002 | 0.003 | 0.004 | 0 |
Changes in Working Capital | 4.121 | -0.296 | -2.345 | -6.154 | -1.119 |
Cash From Investing Activities | 12.186 | -2.757 | -5.386 | -3.501 | -10.669 |
Capital Expenditures | -2.343 | -4.461 | -6.924 | -7.915 | -3.081 |
Other Investing Cash Flow Items, Total | 14.529 | 1.704 | 1.538 | 4.414 | -7.588 |
Cash From Financing Activities | 2.262 | 6.043 | 7.83 | 9.171 | 0.503 |
Financing Cash Flow Items | -1.519 | -1.578 | -1.871 | -2.013 | -0.962 |
Issuance (Retirement) of Stock, Net | 3.781 | 7.621 | 9.701 | 11.184 | 1.465 |
Net Change in Cash | 24.534 | 18.141 | 20.933 | 34.71 | -6.698 |
Issuance (Retirement) of Debt, Net | 0 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
Brown Capital Management, LLC | Investment Advisor | 15.6909 | 7409690 | 61803 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 14.2412 | 6725114 | 96827 | 2022-09-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 6.8329 | 3226682 | 88923 | 2022-09-30 | LOW |
RTW Investments L.P. | Investment Advisor/Hedge Fund | 6.5644 | 3099904 | -423000 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 6.545 | 3090736 | -309999 | 2022-09-30 | LOW |
Conestoga Capital Advisors, LLC | Investment Advisor | 5.2506 | 2479475 | 951154 | 2022-12-31 | LOW |
Fisher Investments | Investment Advisor/Hedge Fund | 3.0105 | 1421635 | -18228 | 2022-09-30 | LOW |
Morgan Stanley & Co. LLC | Research Firm | 2.9501 | 1393120 | -189268 | 2022-09-30 | MED |
Macquarie Investment Management | Investment Advisor | 2.6376 | 1245576 | -297614 | 2022-09-30 | LOW |
GW&K Investment Management, LLC | Investment Advisor | 2.5323 | 1195811 | 84919 | 2022-09-30 | LOW |
New York State Common Retirement Fund | Pension Fund | 2.1919 | 1035067 | 19492 | 2022-12-31 | LOW |
BNP Paribas Asset Management USA, Inc. | Investment Advisor | 2.1372 | 1009232 | 248657 | 2022-09-30 | LOW |
Loomis, Sayles & Company, L.P. | Investment Advisor/Hedge Fund | 2.1315 | 1006550 | 186477 | 2022-09-30 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 1.9102 | 902048 | -379928 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7638 | 832928 | 13232 | 2022-09-30 | LOW |
Fred Alger Management, LLC | Investment Advisor/Hedge Fund | 1.6586 | 783225 | -1161353 | 2022-12-31 | MED |
BNP Paribas Asset Management UK Limited | Investment Advisor | 1.3194 | 623060 | 32962 | 2022-12-31 | LOW |
JPMorgan Asset Management U.K. Limited | Investment Advisor/Hedge Fund | 1.2072 | 570077 | 3001 | 2022-09-30 | LOW |
Kopp Investment Advisors, LLC | Investment Advisor | 1.171 | 552963 | -10 | 2022-09-30 | |
Granahan Investment Management, Inc. | Investment Advisor | 1.1475 | 541870 | -30123 | 2022-09-30 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com GroupKauplejad
Igakuiste aktiivsete klientide arv
Igakuine investeerimise maht
Igakuiselt välja võetud
Kauplemiskalkulaator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Vericel Corp Ord Company profile
Ettevõttest Vericel Corp Ord
Vericel Corporation on kommertsjärgus biofarmatseutiline ettevõte. Ettevõte on spetsialiseerunud rakuteraapiatele ja spetsiaalsetele bioloogilistele ravimitele spordimeditsiini ja raskete põletushaavade jaoks. Ettevõte tegutseb ühes avalikustatavas segmendis, milleks on konkreetsete haiguste raviks kasutatavate rakuteraapiate uurimine, tootearendus, tootmine ja turustamine. Ta turustab Ameerika Ühendriikides kahte autoloogset rakuteraapiatoodet, mille hulka kuuluvad MACI (autoloogsed kultiveeritud kondrotsüüdid seakollageenimembraanil) ja Epicel (kultiveeritud epidermise autotransplantaadid). MACI on autoloogne tselluloosne kärgtoote, mis on näidustatud sümptomaatiliste, ühekordsete või mitmekordsete täispikkuste põlve kõhredefektide raviks koos luukahjustusega või ilma selleta täiskasvanutel. Epicel on püsiv nahka asendav humanitaarotstarbeline seade (HUD), mis on mõeldud täiskasvanud ja pediaatriliste patsientide raviks, kellel on sügava naha või kogu keha pindalast vähemalt 30% moodustav põletushaav.
Industry: | Biopharmaceuticals |
64 Sidney St
CAMBRIDGE
MASSACHUSETTS 02139-4170
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 485,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com